Correlation Between Johnson Johnson and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Monopar Therapeutics, you can compare the effects of market volatilities on Johnson Johnson and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Monopar Therapeutics.
Diversification Opportunities for Johnson Johnson and Monopar Therapeutics
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Johnson and Monopar is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Johnson Johnson and Monopar Therapeutics
Considering the 90-day investment horizon Johnson Johnson is expected to generate 54.96 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Johnson Johnson is 6.13 times less risky than Monopar Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.39 of returns per unit of risk over similar time horizon. If you would invest 2,534 in Monopar Therapeutics on October 26, 2024 and sell it today you would earn a total of 1,581 from holding Monopar Therapeutics or generate 62.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Monopar Therapeutics
Performance |
| Timeline |
| Johnson Johnson |
| Monopar Therapeutics |
Johnson Johnson and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Monopar Therapeutics
The main advantage of trading using opposite Johnson Johnson and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Johnson Johnson vs. Collegium Pharmaceutical | Johnson Johnson vs. Phibro Animal Health | Johnson Johnson vs. ANI Pharmaceuticals | Johnson Johnson vs. Procaps Group SA |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |